Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic

The development of a new lesion in a patient with a complete remission to anti-PD-1 therapy is highly concerning for a drug resistant escape lesion. Here, we present a case of a 62-year-old patient with chemotherapy-resistant metastatic urothelial cancer who had a complete remission to pembrolizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Melms, Johannes C., Thummalapalli, Rohit, Shaw, Kristin, Ye, Huihui, Tsai, Leo, Bhatt, Rupal S., Izar, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134551/
https://www.ncbi.nlm.nih.gov/pubmed/30208947
http://dx.doi.org/10.1186/s40425-018-0394-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134551/
https://www.ncbi.nlm.nih.gov/pubmed/30208947
http://dx.doi.org/10.1186/s40425-018-0394-y

Ejemplares similares